Cell banks are providing the facility to store cells of the specific genome for future use as a product or in medicinal applications. Cell banks are preserving the cells at much below freezing temperature. Cell bank creation is a process to store different types of cells for the treatment of life-threatening diseases in the future. The demand for cell bank creation is increasing as they are useful for the treatment of various types of diseases and experimental evaluations. Collection and transportation of cells are gaining interest to preserve cells in the cell bank. Cell bank creation provides detail characterization of cell lines and lessening cross-contamination of a cell line. Cell bank creation can also be beneficial to reduce the cost of cell culture processes and provide a cost-efficient alternative to keep cells in a culture constantly. Utilizing cell banks will also effectively reduce the frequency of cell sampling from natural resources over time. Cell bank creation is very demanding nowadays to store stem cells and non-stem cells. Cell bank creation will be very beneficial in the field of Lifesciences particularly by storing the stem cells. Stem cells are very important, they are undifferentiated cells and can be divided into specialized cells, tissue, or organ. The demand for stem cells is increasing day by day as they are very useful for the treatment of various blood-related disorders. Cell bank creation will help in the fields of pharmaceuticals and stem cell research by preserving the cells for a long time. Government, as well as non-government organizations, are taking initiative for the cell bank creation thereby influencing the cell bank creation market growth. However, increasing prevalence of chronic diseases is expected to provide a better platform for the cell bank creation market.
The technological advancement and increased expectancy of human life will drive the demand for cell bank creation market. Increasing approval of clinical trials in the field of medicine and organ transplantation will be expected to drive the cell bank creation market. Increasing awareness among the individuals about the importance of preserving stem cells and other cells will be expected to drive the cell bank creation market. The initiative was taken by regulatory authorities and non-government organizations (NGO) towards the preservation of different types of the cell will be expected to drive the cell bank creation market. Rising prevalence of chronic diseases will also be expected to drive the cell bank creation market. However, high storage and processing cost and lack of awareness and acceptance in developing regions adversely affect the growth of the cell bank creation market.
The cell bank creation market can be segmented by cell type, bank type, application and end-user.
Based on the cell type the cell bank creation market can be segmented as
Based on the cell bank type the cell bank creation market can be segmented as
Based on the application the cell bank creation market can be segmented as
Based on the end-user the cell bank creation market can be segmented as
Cell bank creation will provide better market opportunities to the key market players during the forecast period because of the increasing interest among the researchers and clinicians of preserving cells to use in experimental and medicinal applications. The potential of stem cells in the application of gene therapy, tissue engineering and regenerative medicine is expected to provide huge growth to the cell bank creation market. The importance of preserving different types of cells for potential future use will be expected to provide immense market growth of cell bank creation in the forecasting periods. Further, the increasing prevalence of life-threatening chronic diseases will also be expected to drive the cell bank creation market.
The U.S. is anticipated as the leading cell bank creation market due to higher healthcare funds, technological advancement, and demand for cell preservation among the clinicians and researchers. Government and non-government initiatives will also provide huge support towards cell bank creation in the U.S. The market of cell bank creation is also expected to be high because of the awareness and big budgets by government and non-government organizations towards research and innovation of new technologies. However, the South Asian countries such as India and China, the opportunities to create cell bank is higher due to the increasing economy and government initiatives towards research and development in health care, which is expected to provide ample opportunities on cell bank creation among the market players.
Examples of some of the key players operating in the cell bank creation market are Thermo Fisher Scientific Inc., SGS Life Sciences, Lonza Group AG, VCANBIO Cell & Gene Engineering Corporation, Ltd., AMAG Pharmaceuticals, ViaCord (PerkinElmer, Inc.), WuXi AppTec, Inc., ESPERITE N.V., Reliance Life Sciences Ltd., LifeCell International Pvt. Ltd., Cryo-Cell Plc., Toxikon, Goodwin Biotechnology Inc.( Wallace Pharmaceuticals Ltd.), among others.
The report covers exhaustive analysis on: